New strength of Glucophage SR

Merck Serono has a new 1000mg strength of its prolonged-release metformin preparation, Glucophage SR, indicated in the management of type II diabetes either as monotherapy or as adjunct to other therapies.

The 1000mg tablets will reduce the tablet burden on patients prescribed a high dose of metformin SR, allowing for easier administration.

The 1000mg tablets are intended for patients who have already been treated with metformin sustained-release or immediate-release preparations.

View Glucophage SR drug record

Further information: Merck Serono

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in